Figure 3.

Outcome after surgical resection given by Kaplan-Meier analysis of overall survival (OS) according to LAT1, ASCT2 and CD98 expression. A statistically significant difference in OS was observed between patients with positive and negative LAT1 expression (A). There was not statistically different between patients with positive and negative ASCT2 expression (B), and between patients with positive and negative CD98 expression (C). Survival analysis according to FIGO staging (early or advanced stage) showed that patients with a positive LAT1 expression achieved worse prognosis in stage I/II (D) and stage III/IV (E) than those with negative LAT1 expression.